In addition, secondary antitumor necrosis factor α (anti-TNF α)-induced or anti-TNF α-associated ON has been reported in association with the wider use of anti-TNF α therapy for a variety of autoimmune diseases, including IBD and MS [20,21,22,23,24]. Here, TNF is linked to inflammatory bowel disease.